🇺🇸 FDA
Patent

US 11090269

Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

granted A61KA61K31/19A61K9/2054

Quick answer

US patent 11090269 (Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances) held by Jazz Pharmaceuticals, Inc. expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals, Inc.
Grant date
Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/19, A61K9/2054, A61K9/209, A61K9/2833